TranslAGE: A Unified Platform to Build and Translate Aging Biomarkers into Clinical Surrogate Endpoints

Abstract

Evaluating the effectiveness of lifespan- and healthspan-extending interventions in human clinical trials requires robust surrogate endpoints. Omics-based aging biomarkers hold promise but face limitations: narrow validation efforts, lack of standardization, and population biases.